Cytek Biosciences Maximum Drawdown

CTKB Stock  USD 3.52  0.22  5.88%   
Cytek Biosciences maximum-drawdown technical analysis lookup allows you to check this and other technical indicators for Cytek Biosciences or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Cytek Biosciences has current Maximum Drawdown of 27.48. Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough.

Maximum Drawdown

=

MAX(HIGH - LOW)

 = 
27.48
MAX = Maximum notation for the range of returns on Cytek Biosciences

Cytek Biosciences Maximum Drawdown Peers Comparison

Cytek Maximum Drawdown Relative To Other Indicators

Cytek Biosciences is rated fourth in maximum drawdown category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about  1.00  of Maximum Drawdown per Maximum Drawdown.
JavaScript chart by amCharts 3.21.15RXSTLUNGAPYXSGHTAXGNKIDSCTKB 01020304050 01020304050
The MDD is one of the most important risk measures. It measures the loss in any losing period and is usually defined as the percent retrenchment from an asset peak value to the valley value. Maximum drawdown encompasses both the period from the peak to the valley (length), and the time from the valley to a new high (recovery). It measures the largest percentage drawdown that has occurred in a given time period.
Compare Cytek Biosciences to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Assets

APYX
Apyx Medical
0.88  -0.02  -2.22 
LUNG
Pulmonx Corp
5.21  -0.22  -4.05 
TMCI
Treace Medical Concepts
6.99  -0.42  -5.67 
VAPO
Vapotherm
0.00  0.00  0.00 
INGN
Inogen Inc
7.08  0.49  7.44 
AXGN
Axogen Inc
15.80  -0.96  -5.73 
LIVN
LivaNova PLC
34.14  -1.58  -4.42 
HSKA
Heska
0.00  0.00  0.00 
OFIX
Orthofix Medical
13.92  -0.8  -5.43 
RXST
Rxsight
14.16  -1.35  -8.7 
OSA
ProSomnus, Common Stock
0.00  0.00  0.00 
SSKN
STRATA Skin Sciences
2.51  -0.17  -6.34 
TLIS
Talis Biomedical Corp
0.00  0.00  0.00 
KIDS
Orthopediatrics Corp
21.39  -1.64  -7.12 
SRDX
SurModics
27.24  -1.01  -3.58 
NPCE
Neuropace
10.64  -1.03  -8.83 
SGHT
Sight Sciences
2.26  -0.09  -3.83 
ELMD
Electromed
22.59  -0.94  -3.99